The Cardiovascular Risk of White-Coat Hypertension.
Franklin SS, Thijs L, Asayama K, Li Y, Hansen TW, Boggia J, Jacobs L, Zhang Z, Kikuya M, Björklund-Bodegård K, Ohkubo T, Yang WY, Jeppesen J, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Filipovský J, Imai Y, Wang JG, O'Brien E, Staessen JA; IDACO Investigators.
Franklin SS, et al.
J Am Coll Cardiol. 2016 Nov 8;68(19):2033-2043. doi: 10.1016/j.jacc.2016.08.035.
J Am Coll Cardiol. 2016.
PMID: 27810041
Free article.
BACKGROUND: The role of white-coat hypertension (WCH) and the white-coat-effect (WCE) in development of cardiovascular disease (CVD) risk remains poorly understood. ...
BACKGROUND: The role of white-coat hypertension (WCH) and the white-coat-effect (WCE) in development of cardiovascular disease …